Dr Pepper Snapple's Lofty Valuation Leaves a Sour Taste
With limited revenue growth and margin expansion opportunities, a narrow moat still can't justify the stock price.
Dr Pepper Snapple Group (DPS) has enjoyed market share gains and margin expansion over the past several years, but we think the company's already best-in-class profitability and secularly slower top-line growth opportunities leave it overvalued versus peers Coca-Cola (KO) and PepsiCo (PEP).
The U.S. soft drink industry makes up nearly all of Dr Pepper's earnings, and while we're not as pessimistic on the geography's future growth as some, given continued price rationality and gains in juices, water, and other noncarbonated beverages, we expect further declines in carbonated drinks will limit the country's growth rate to the low single digits. Moreover, we see limited upside in Dr Pepper's margins, given already solid comparisons to industry leaders Coca-Cola and PepsiCo.
Adam Fleck does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.